chemotherapy: be for cancer

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be for cancer 1.00
be for just cancer 0.97
has state cancer 0.95
be just used for cancer 0.94
treat cancer 0.92
be used for breast cancer 0.90
be more important than other cancer 0.90
be effective in cancer treatment 0.89
be for lymphoma 0.89
be for lymphoma determined 0.88

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.56
Rule weight: 0.66
Evidence weight: 0.95
Similarity weight: 0.89
Evidence: 0.91
Plausible(treatment, be for lymphoma)
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)
0.56
Rule weight: 0.66
Evidence weight: 0.96
Similarity weight: 0.88
Evidence: 0.93
Plausible(treatment, be for lymphoma determined)
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)
0.55
Rule weight: 0.66
Evidence weight: 0.92
Similarity weight: 0.89
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.67
Similarity weight: 0.89
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.85
¬ Plausible(agent, be effective in cancer treatment)
0.05
Rule weight: 0.09
Evidence weight: 0.65
Similarity weight: 0.89
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.91
¬ Plausible(treatment, be for lymphoma)
0.05
Rule weight: 0.09
Evidence weight: 0.64
Similarity weight: 0.88
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.93
¬ Plausible(treatment, be for lymphoma determined)

Remarkability exclusitivity betweem a parent and a child

0.33
Rule weight: 0.58
Evidence weight: 0.64
Similarity weight: 0.89
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.43
¬ Remarkable(agent, be effective in cancer treatment)
0.29
Rule weight: 0.58
Evidence weight: 0.57
Similarity weight: 0.89
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma)
0.29
Rule weight: 0.58
Evidence weight: 0.57
Similarity weight: 0.88
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.51
¬ Remarkable(treatment, be for lymphoma determined)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.50
Similarity weight: 0.92
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.58
¬ Remarkable(gene therapy, treat cancer)
0.05
Rule weight: 0.13
Evidence weight: 0.45
Similarity weight: 0.90
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.65
¬ Remarkable(breast cancer, be more important than other cancer)
0.03
Rule weight: 0.13
Evidence weight: 0.27
Similarity weight: 0.95
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.86
¬ Remarkable(breast cancer, has state cancer)

Remarkability from parent implausibility

0.37
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.89
Evidence: 0.91
Plausible(treatment, be for lymphoma)
Evidence: 0.85
Remarkable(chemotherapy, be for cancer)
Evidence: 0.61
¬ Plausible(chemotherapy, be for cancer)
0.37
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.89
Evidence: 0.85
Plausible(agent, be effective in cancer treatment)
Evidence: 0.85
Remarkable(chemotherapy, be for cancer)
Evidence: 0.61
¬ Plausible(chemotherapy, be for cancer)
0.37
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.88
Evidence: 0.93
Plausible(treatment, be for lymphoma determined)
Evidence: 0.85
Remarkable(chemotherapy, be for cancer)
Evidence: 0.61
¬ Plausible(chemotherapy, be for cancer)

Remarkability from sibling implausibility

0.56
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.95
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.86
Remarkable(breast cancer, has state cancer)
Evidence: 0.32
¬ Plausible(breast cancer, has state cancer)
0.48
Rule weight: 0.60
Evidence weight: 0.86
Similarity weight: 0.92
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.58
Remarkable(gene therapy, treat cancer)
Evidence: 0.84
¬ Plausible(gene therapy, treat cancer)
0.48
Rule weight: 0.60
Evidence weight: 0.88
Similarity weight: 0.90
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.65
Remarkable(breast cancer, be more important than other cancer)
Evidence: 0.86
¬ Plausible(breast cancer, be more important than other cancer)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.81
¬ Salient(chemotherapy, be for cancer)

Similarity expansion

0.74
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.97
Evidence: 0.85
Remarkable(chemotherapy, be for cancer)
Evidence: 0.67
¬ Remarkable(chemotherapy, be for just cancer)
0.71
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.94
Evidence: 0.85
Remarkable(chemotherapy, be for cancer)
Evidence: 0.81
¬ Remarkable(chemotherapy, be just used for cancer)
0.68
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.90
Evidence: 0.85
Remarkable(chemotherapy, be for cancer)
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer)
0.68
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.97
Evidence: 0.81
Salient(chemotherapy, be for cancer)
Evidence: 0.94
¬ Salient(chemotherapy, be for just cancer)
0.67
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.94
Evidence: 0.81
Salient(chemotherapy, be for cancer)
Evidence: 0.89
¬ Salient(chemotherapy, be just used for cancer)
0.63
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.90
Evidence: 0.81
Salient(chemotherapy, be for cancer)
Evidence: 0.92
¬ Salient(chemotherapy, be used for breast cancer)
0.58
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.94
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.73
¬ Plausible(chemotherapy, be just used for cancer)
0.55
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.97
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.87
¬ Plausible(chemotherapy, be for just cancer)
0.54
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.94
Evidence: 0.52
Typical(chemotherapy, be for cancer)
Evidence: 0.68
¬ Typical(chemotherapy, be just used for cancer)
0.53
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.90
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.81
¬ Plausible(chemotherapy, be used for breast cancer)
0.48
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.90
Evidence: 0.52
Typical(chemotherapy, be for cancer)
Evidence: 0.79
¬ Typical(chemotherapy, be used for breast cancer)
0.47
Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.97
Evidence: 0.52
Typical(chemotherapy, be for cancer)
Evidence: 0.90
¬ Typical(chemotherapy, be for just cancer)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.81
Salient(chemotherapy, be for cancer)
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.61
Plausible(chemotherapy, be for cancer)
Evidence: 0.52
¬ Typical(chemotherapy, be for cancer)

Typicality and Rermarkability incompatibility between a parent and a child

0.09
Rule weight: 0.51
Evidence weight: 0.20
Similarity weight: 0.89
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)
0.08
Rule weight: 0.51
Evidence weight: 0.18
Similarity weight: 0.89
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.96
¬ Typical(treatment, be for lymphoma)
0.08
Rule weight: 0.51
Evidence weight: 0.17
Similarity weight: 0.88
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined)

Typicality and Rermarkability incompatibility between siblings

0.11
Rule weight: 0.14
Evidence weight: 0.85
Similarity weight: 0.95
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.17
¬ Typical(breast cancer, has state cancer)
0.03
Rule weight: 0.14
Evidence weight: 0.24
Similarity weight: 0.92
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.89
¬ Typical(gene therapy, treat cancer)
0.03
Rule weight: 0.14
Evidence weight: 0.23
Similarity weight: 0.90
Evidence: 0.85
¬ Remarkable(chemotherapy, be for cancer)
Evidence: 0.91
¬ Typical(breast cancer, be more important than other cancer)

Typicality inheritance from parent to child

0.24
Rule weight: 0.48
Evidence weight: 0.55
Similarity weight: 0.89
Evidence: 0.52
Typical(chemotherapy, be for cancer)
Evidence: 0.94
¬ Typical(agent, be effective in cancer treatment)
0.23
Rule weight: 0.48
Evidence weight: 0.54
Similarity weight: 0.89
Evidence: 0.52
Typical(chemotherapy, be for cancer)
Evidence: 0.96
¬ Typical(treatment, be for lymphoma)
0.23
Rule weight: 0.48
Evidence weight: 0.53
Similarity weight: 0.88
Evidence: 0.52
Typical(chemotherapy, be for cancer)
Evidence: 0.98
¬ Typical(treatment, be for lymphoma determined)